QUALITY OF LIFE BEFORE AND AFTER OPERATION IN PATIENTS WITH DIFFUSE TOXIC GOITER
Article Sidebar
Main Article Content
Abstract:
By the main criteria for the effectiveness of treatment of thyrotoxicosis, most researchers mean the elimination of thyrotoxicosis and the achievement of immunological remission. However, according to domestic and foreign literature in recent years, many scientists consider quality of life (QOL) to be the most reliable and sensitive criterion for assessing the results and effectiveness of therapy. Disability is measured by assessing the patient's behavior as he performs specific actions in specific situations under certain conditions and is an important indicator that contributes to the understanding of the relationship between damage, the disease process and its outcome. In recent years, the concept of “health-related quality of life (QOL)” has been increasingly used, which is considered as a holistic characteristic of the physical, mental, emotional and social state of the patient, based on his subjective perception.
Article Details
How to Cite:
References:
Gullo, D. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients // PLoS One. – 2011. – Vol. 6. – Is. 8. – e22552. – P. 1-7.
Hovens, G.C.J. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with, de novo Graves disease // Clin. Endocrinol. – 2006. – N. 4. – P. 429-435.
Noguchi, H. Surgical management of Grave’s disease, past and future // 12th Congress of Asian Association of Endocrine Surgeons, 2010. – March 23–24.
Improvement of tactical and technical aspects of surgical treatment of diffus toxic goiter. International Scientific Journal Theoretical & Applied Science 2021. Nishanov M.F., Aliboev M.R., Akhmadbekov B.O. 2021-y.
Troshina, E.A. Principles of thyrostatic therapy of Graves' disease (lecture) // Сonsilium medicum. - 2012. - T. 12. - No. 12. - S. 64-68.
Tsurkan, A.Yu. Evaluation of the influence of various factors on the outcome of subtotal resection of the thyroid gland in Graves' disease. Clinical and experimental thyroidology. - 2011. - T. 7. - No. 1. - S. 50-54.
Sheremeta, M.S. Clinical course of endocrine ophthalmopathy in Graves' disease depending on the effect of radioiodine therapy // Problems of Endocrinology. - 2011. - No. 3. - P. 17–20.